326 related articles for article (PubMed ID: 16857310)
21. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
Ganzer R; Robertson CN; Ward JF; Brown SC; Conti GN; Murat FJ; Pasticier G; Rebillard X; Thuroff S; Wieland WF; Blana A
BJU Int; 2011 Oct; 108(8 Pt 2):E196-201. PubMed ID: 21332907
[TBL] [Abstract][Full Text] [Related]
22. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
[TBL] [Abstract][Full Text] [Related]
23. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
24. High-intensity focused ultrasound in prostate cancer: results after 3 years.
Chaussy C; Thüroff S
Mol Urol; 2000; 4(3):179-82. PubMed ID: 11062372
[TBL] [Abstract][Full Text] [Related]
25. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
[TBL] [Abstract][Full Text] [Related]
26. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
[TBL] [Abstract][Full Text] [Related]
27. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.
Hayashi M; Shinmei S; Asano K
Int J Urol; 2007 Nov; 14(11):1048-50. PubMed ID: 17956536
[TBL] [Abstract][Full Text] [Related]
28. Failure to achieve a PSA level Mitchell DM; McAleese J; Park RM; Stewart DP; Stranex S; Eakin RL; Houston RF; O'Sullivan JM
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1467-71. PubMed ID: 17689886
[TBL] [Abstract][Full Text] [Related]
29. [High intensity focused ultrasound in localized prostate cancer].
Coulange C
Cancer Radiother; 2005 Nov; 9(6-7):377-8. PubMed ID: 16168696
[TBL] [Abstract][Full Text] [Related]
30. Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry.
Blana A; Robertson CN; Brown SC; Chaussy C; Crouzet S; Gelet A; Conti GN; Ganzer R; Pasticier G; Thuroff S; Ward JF
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):256-9. PubMed ID: 22487909
[TBL] [Abstract][Full Text] [Related]
31. [Treatment by HIFU of prostate cancer: survey of literature and treatment indications].
Rébillard X; Davin JL; Soulié M;
Prog Urol; 2003 Dec; 13(6):1428-56. PubMed ID: 15000326
[TBL] [Abstract][Full Text] [Related]
32. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
33. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
[TBL] [Abstract][Full Text] [Related]
34. Local control of prostate cancer by transrectal HIFU-therapy.
Kiel HJ; Wieland WF; Rössler W
Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
[TBL] [Abstract][Full Text] [Related]
35. Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience.
Mearini L; D'Urso L; Collura D; Zucchi A; Costantini E; Formiconi A; Bini V; Muto G; Porena M
J Urol; 2009 Jan; 181(1):105-11; discussion 111-2. PubMed ID: 19081465
[TBL] [Abstract][Full Text] [Related]
36. An analysis of men with clinically localized prostate cancer who deferred definitive therapy.
Patel MI; DeConcini DT; Lopez-Corona E; Ohori M; Wheeler T; Scardino PT
J Urol; 2004 Apr; 171(4):1520-4. PubMed ID: 15017211
[TBL] [Abstract][Full Text] [Related]
37. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
38. Outcome analysis of prostate cancer patients with pre-treatment PSA greater than 50 ng/ml.
Wiebe E; Rodrigues G; Lock M; D'Souza D; Stitt L
Can J Urol; 2008 Jun; 15(3):4078-83. PubMed ID: 18570713
[TBL] [Abstract][Full Text] [Related]
39. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
[TBL] [Abstract][Full Text] [Related]
40. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer.
Muto S; Yoshii T; Saito K; Kamiyama Y; Ide H; Horie S
Jpn J Clin Oncol; 2008 Mar; 38(3):192-9. PubMed ID: 18281309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
